Cost effectiveness of group follow-up after structured education for type 1 diabetes: a cluster randomised controlled trial.

Hdl Handle:
http://hdl.handle.net/10147/322573
Title:
Cost effectiveness of group follow-up after structured education for type 1 diabetes: a cluster randomised controlled trial.
Authors:
Gillespie, Paddy; O'Shea, Eamon; O Hara, Mary Clare; Dinneen, Sean F
Citation:
Cost effectiveness of group follow-up after structured education for type 1 diabetes: a cluster randomised controlled trial. 2014, 15 (1):227 Trials
Publisher:
Trials
Journal:
Trials
Issue Date:
14-Jun-2014
URI:
http://hdl.handle.net/10147/322573
DOI:
10.1186/1745-6215-15-227
PubMed ID:
24927851
Abstract:
This study examines the cost effectiveness of group follow-up after participation in the Dose Adjustment for Normal Eating (DAFNE) structured education programme for type 1 diabetes.; Economic evaluation conducted alongside a cluster randomised controlled trial involving 437 adults with type 1 diabetes in Ireland. Group follow-up involved two group education 'booster' sessions post-DAFNE. Individual follow-up involved two standard one-to-one hospital clinic visits. Incremental costs, quality-adjusted life years (QALYs) gained and cost effectiveness were estimated at 18 months. Uncertainty was explored using sensitivity analysis and by estimating cost effectiveness acceptability curves.; Group follow-up was associated with a mean reduction in QALYs gained of 0.04 per patient (P value, 0.052; 95% CI, -0.08 to 0.01, intra-class correlation (ICC), 0.033) and a mean reduction in total healthcare costs of [euro sign]772 (P value, 0.020; 95% CI, -1,415 to -128: ICC, 0.016) per patient. At alternative threshold values of [euro sign]5,000, [euro sign]15,000, [euro sign]25,000, [euro sign]35,000, and [euro sign]45,000, the probability of group follow-up being cost effective was estimated to be 1.000, 0.762, 0.204, 0.078, and 0.033 respectively.; The results do not support implementation of group follow-up as the sole means of follow-up post-DAFNE. Given the reported cost savings, future studies should explore the cost effectiveness of alternative models of group care for diabetes.Trial registration: Current Controlled Trials ISRCTN79759174 (assigned: 9 February 2007).
Item Type:
Article
Language:
en
Description:
BACKGROUND: This study examines the cost effectiveness of group follow-up after participation in the Dose Adjustment for Normal Eating (DAFNE) structured education programme for type 1 diabetes. METHODS: Economic evaluation conducted alongside a cluster randomised controlled trial involving 437 adults with type 1 diabetes in Ireland. Group follow-up involved two group education 'booster' sessions post-DAFNE. Individual follow-up involved two standard one-to-one hospital clinic visits. Incremental costs, quality-adjusted life years (QALYs) gained and cost effectiveness were estimated at 18 months. Uncertainty was explored using sensitivity analysis and by estimating cost effectiveness acceptability curves. RESULTS: Group follow-up was associated with a mean reduction in QALYs gained of 0.04 per patient (P value, 0.052; 95% CI, -0.08 to 0.01, intra-class correlation (ICC), 0.033) and a mean reduction in total healthcare costs of [euro sign]772 (P value, 0.020; 95% CI, -1,415 to -128: ICC, 0.016) per patient. At alternative threshold values of [euro sign]5,000, [euro sign]15,000, [euro sign]25,000, [euro sign]35,000, and [euro sign]45,000, the probability of group follow-up being cost effective was estimated to be 1.000, 0.762, 0.204, 0.078, and 0.033 respectively. CONCLUSIONS: The results do not support implementation of group follow-up as the sole means of follow-up post-DAFNE. Given the reported cost savings, future studies should explore the cost effectiveness of alternative models of group care for diabetes.
Keywords:
DIABETES MELLITUS; COST EFFECTIVENESS
ISSN:
1745-6215

Full metadata record

DC FieldValue Language
dc.contributor.authorGillespie, Paddyen_GB
dc.contributor.authorO'Shea, Eamonen_GB
dc.contributor.authorO Hara, Mary Clareen_GB
dc.contributor.authorDinneen, Sean Fen_GB
dc.date.accessioned2014-07-08T10:10:17Z-
dc.date.available2014-07-08T10:10:17Z-
dc.date.issued2014-06-14-
dc.identifier.citationCost effectiveness of group follow-up after structured education for type 1 diabetes: a cluster randomised controlled trial. 2014, 15 (1):227 Trialsen_GB
dc.identifier.issn1745-6215-
dc.identifier.pmid24927851-
dc.identifier.doi10.1186/1745-6215-15-227-
dc.identifier.urihttp://hdl.handle.net/10147/322573-
dc.descriptionBACKGROUND: This study examines the cost effectiveness of group follow-up after participation in the Dose Adjustment for Normal Eating (DAFNE) structured education programme for type 1 diabetes. METHODS: Economic evaluation conducted alongside a cluster randomised controlled trial involving 437 adults with type 1 diabetes in Ireland. Group follow-up involved two group education 'booster' sessions post-DAFNE. Individual follow-up involved two standard one-to-one hospital clinic visits. Incremental costs, quality-adjusted life years (QALYs) gained and cost effectiveness were estimated at 18 months. Uncertainty was explored using sensitivity analysis and by estimating cost effectiveness acceptability curves. RESULTS: Group follow-up was associated with a mean reduction in QALYs gained of 0.04 per patient (P value, 0.052; 95% CI, -0.08 to 0.01, intra-class correlation (ICC), 0.033) and a mean reduction in total healthcare costs of [euro sign]772 (P value, 0.020; 95% CI, -1,415 to -128: ICC, 0.016) per patient. At alternative threshold values of [euro sign]5,000, [euro sign]15,000, [euro sign]25,000, [euro sign]35,000, and [euro sign]45,000, the probability of group follow-up being cost effective was estimated to be 1.000, 0.762, 0.204, 0.078, and 0.033 respectively. CONCLUSIONS: The results do not support implementation of group follow-up as the sole means of follow-up post-DAFNE. Given the reported cost savings, future studies should explore the cost effectiveness of alternative models of group care for diabetes.en_GB
dc.description.abstractThis study examines the cost effectiveness of group follow-up after participation in the Dose Adjustment for Normal Eating (DAFNE) structured education programme for type 1 diabetes.-
dc.description.abstractEconomic evaluation conducted alongside a cluster randomised controlled trial involving 437 adults with type 1 diabetes in Ireland. Group follow-up involved two group education 'booster' sessions post-DAFNE. Individual follow-up involved two standard one-to-one hospital clinic visits. Incremental costs, quality-adjusted life years (QALYs) gained and cost effectiveness were estimated at 18 months. Uncertainty was explored using sensitivity analysis and by estimating cost effectiveness acceptability curves.-
dc.description.abstractGroup follow-up was associated with a mean reduction in QALYs gained of 0.04 per patient (P value, 0.052; 95% CI, -0.08 to 0.01, intra-class correlation (ICC), 0.033) and a mean reduction in total healthcare costs of [euro sign]772 (P value, 0.020; 95% CI, -1,415 to -128: ICC, 0.016) per patient. At alternative threshold values of [euro sign]5,000, [euro sign]15,000, [euro sign]25,000, [euro sign]35,000, and [euro sign]45,000, the probability of group follow-up being cost effective was estimated to be 1.000, 0.762, 0.204, 0.078, and 0.033 respectively.-
dc.description.abstractThe results do not support implementation of group follow-up as the sole means of follow-up post-DAFNE. Given the reported cost savings, future studies should explore the cost effectiveness of alternative models of group care for diabetes.Trial registration: Current Controlled Trials ISRCTN79759174 (assigned: 9 February 2007).-
dc.languageENG-
dc.language.isoenen
dc.publisherTrialsen_GB
dc.rightsArchived with thanks to Trialsen_GB
dc.subjectDIABETES MELLITUSen_GB
dc.subjectCOST EFFECTIVENESSen_GB
dc.titleCost effectiveness of group follow-up after structured education for type 1 diabetes: a cluster randomised controlled trial.en_GB
dc.typeArticleen
dc.identifier.journalTrialsen_GB

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.